FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 141 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 5.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $223,000 | -59.4% | 5,440 | -50.4% | 0.01% | -62.5% |
| Q4 2016 | $549,000 | -8.3% | 10,957 | -4.0% | 0.02% | -5.9% |
| Q3 2016 | $599,000 | +24.5% | 11,410 | -1.8% | 0.02% | +21.4% |
| Q2 2016 | $481,000 | -8.7% | 11,625 | -10.4% | 0.01% | -12.5% |
| Q1 2016 | $527,000 | -34.8% | 12,977 | -33.4% | 0.02% | -33.3% |
| Q4 2015 | $808,000 | +5.1% | 19,472 | -61.0% | 0.02% | +4.3% |
| Q3 2015 | $769,000 | -28.8% | 49,954 | +14.8% | 0.02% | -23.3% |
| Q2 2015 | $1,080,000 | – | 43,503 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |